A Personalized Approach: The Role of Commercially Available Genetic Tests
Prostate Cancer is the most commonly diagnosed malignancy in American men. Patients and their doctors face many challenges when it […]
Prostate Cancer is the most commonly diagnosed malignancy in American men. Patients and their doctors face many challenges when it […]
After prostate cancer is treated, patients usually undergo a blood test called PSA. PSA stands for Prostate Specific Antigen and […]
When given the option of another piece of cake, most toddlers will automatically respond with more cake, because more is […]
Shipley Foundation gift will fund research in personalized medicine Each year, more than 100,000 men diagnosed with prostate cancer in […]
Boston University trustee Richard Shipley, a School of Management Class of 1972 graduate, donated $10.5 million to the BU School […]
Boston University has announced a $10.5 million grant from trustee and alumnus Richard C. Shipley to create a prostate cancer […]